Northwest Biotherapeutics (NWBO) Other Operating Expenses (2014 - 2026)

Northwest Biotherapeutics' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Other Operating Expenses changed N/A year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (changed N/A YoY), while the FY2018 annual figure was $3.3 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $2.2 million, down from $16.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was $2.2 million in Q1 2026, with the low at $2.2 million in Q1 2026.